 |
chimeric antigen receptor directed against the target protein CD4 lentivirally transfected T cells |
|---|---|
| Trade Name | |
| Orphan Indication | T-cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2016-07-28 00:00:00 |
| Sponsor | iCell Gene Therapeutics;25 Health Sciences Drive, Suite 118;Stony Brook, New York, 11793 |
